Probiotics: Finding the Right Regulatory Balance
Year: 2013
Type: article
Abstract: Some products marketed as drugs should be excused from Phase I trials, but safety and efficacy claims for dietary supplements should be more tightly regulated.
Source: Science
Institution: University of Maryland, Baltimore
Language: English
Subfield: Food Science
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W2021601797
